Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hysteroscopic photodynamic diagnosis using 5-aminolevulinic acid for uterine cavity diseases
jRCTs031180123Completed
- Sponsor
- The Japanese Foundation for Research and Promotion of Endoscopy
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in Fibromyoma (LM), endometrial polyp, endometrial cancer (EC) and 2 more, sponsored by The Japanese Foundation for Research and Promotion of Endoscopy. Primary endpoint: Diagnostic accuracy for malignant disease. Started Jun 2019; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
Fibromyoma (LM)endometrial polypendometrial cancer (EC)uterine cancerOther diseases of the uterine cavity
Beyond the preview
Go deeper on jRCTs031180123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180123.